Monday, 17 November 2014

Actavis to buy Botox-maker Allergen $66bn



Actavis is to buy Botox-maker Allergan for $66bn (£42bn) to create one of the top ten biggest pharmaceutical companies in the world. Allergan had spent months fending off a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals. via Pocket http://ift.tt/11k0be0

No comments:

Post a Comment